Illumen Therapeutics Inc.
PrivateLast Round
Pre Seed
Jan 6, 2026
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Illumen Therapeutics Inc. is a biotechnology company developing first-in-class PARN inhibitor drugs to treat aggressive cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Illumen Therapeutics Inc. Comparables
Compare Illumen Therapeutics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vona Oncology | 72% | |
| p53-Therapeutics, Inc. | 66% | |
| Lamassu BioTech | 65% |
Illumen Therapeutics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Jan 6, 2026 |
Illumen Therapeutics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Venture Partners at CU Boulder | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 6, 2026
Led by Venture Partners at CU Boulder.
Illumen Therapeutics Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Illumen Therapeutics Inc.'s valuation, stock price, and market status.
Is Illumen Therapeutics Inc. a public or private company?
Illumen Therapeutics Inc. is a private company.
What is the current stock price of Illumen Therapeutics Inc.?
Illumen Therapeutics Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Illumen Therapeutics Inc. worth (valuation)?
Valuation information for Illumen Therapeutics Inc. is not publicly available.
Can I buy Illumen Therapeutics Inc. stock?
Illumen Therapeutics Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Illumen Therapeutics Inc.'s last funding round?
Illumen Therapeutics Inc.'s most recent funding round was Pre Seed on January 6, 2026.
Who are the main investors in Illumen Therapeutics Inc.?
Key investors in Illumen Therapeutics Inc. include Venture Partners at CU Boulder.
Will Illumen Therapeutics Inc. IPO soon?
No public IPO plans have been announced for Illumen Therapeutics Inc..
How can I track Illumen Therapeutics Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Illumen Therapeutics Inc.'s secondary market activity and sign up for updates.